On June 3, 2026, the European Chemicals Agency (ECHA) published a briefing on the consultation results for the draft opinion of the Socio-Economic Analysis Committee (SEAC) regarding the PFAS restriction proposal. During the 60-day consultation window, ECHA received a total of 3,511 comments from over 3,200 organizations and 250 individuals, with participants spanning industry, civil society, academia, and public institutions. Based on this consultation results briefing, CIRS Group summarizes the following key takeaways.
Background
The PFAS restriction proposal was jointly submitted in January 2023 by five countries—Denmark, Germany, the Netherlands, Norway, and Sweden—with the aim of reducing PFAS environmental emissions. ECHA's Risk Assessment Committee (RAC) adopted its final scientific opinion on the proposal on March 2, 2026, while the socio-economic assessment by SEAC, due to significant controversy, underwent an additional 60-day public consultation.
Sources of Comments
In terms of geographic distribution, Germany ranked first with over 1,000 comments, far exceeding other countries; Japan (approximately 550) and Belgium (approximately 450) followed closely. Nordic and Eastern European countries such as Finland, Denmark, and Poland also demonstrated high levels of engagement.
By commenter type, enterprises were the absolute main contributors, accounting for 61.6% of opinions; industry associations represented 25.9%, with the two categories combined approaching 90%. Individual comments accounted for only 7.7%, while non-governmental organizations (NGOs), national authorities, and academia represented 2.4%, 1.4%, and 0.9% respectively. This structure clearly indicates that the core controversies of the PFAS restriction proposal lie in its impact on the real economy.
Industry Focus Areas
Among the 16 categorized surveys, comments on "general provisions" accounted for as much as 45.1%. Within industry-specific surveys, the electronics and semiconductor sector became the single most closely watched industry at 12.7%; fluorinated gas applications (6.6%), energy (6.2%), transportation (6.1%), and lubricants (5.3%) also received substantial feedback. In contrast, consumer-end sectors such as cosmetics and ski wax accounted for less than 0.5% of comments.
ECHA noted that the vast majority of opinions focused on socio-economic impacts, including the availability of alternative technologies, the length of transition periods, compliance costs, and potential impacts on global competitiveness.
Next Steps
Currently, SEAC is conducting a line-by-line evaluation of all submitted materials. The Committee stated that it will confirm or modify the conclusions in the draft based on evidence-based data, and strives to adopt its final opinion by the end of 2026. At that time, the two final opinions from RAC and SEAC will be formally submitted to the European Commission. The European Commission will draft the final PFAS restriction legislation based on these two scientific assessments, and submit it to the REACH Committee for discussion and vote.
CIRS Testing Insights
At present, PFAS lacks fully equivalent substitutes, particularly in cutting-edge fields such as semiconductor manufacturing (photoresists, etching gases), new energy batteries (binders, separator coatings), and aerospace (high-performance lubricants). Relevant enterprises should promptly inventory PFAS usage scenarios in their product portfolios and assess the maturity of alternative technologies. CIRS Group will closely monitor the final SEAC opinion at the end of 2026 and subsequent REACH Committee voting developments, providing enterprises with the latest PFAS-related information.
V. Services Offered by CIRS Testing
✅ PFAS restricted substance testing under POPs / REACH (PFOA, PFOS, PFHxS, C₉–C₁₄ PFCAs, detection limit at ppb level)
✅ REACH SVHC PFAS screening and SCIP notification agent
✅ Chemical compliance assessment (including PFAS risk analysis) for medical devices under MDR / NMPA
✅ Fluoropolymer material Declaration of Conformity (DoC) review and customised supply chain questionnaire
✅ Total fluorine screening (IC method) + targeted PFAS quantification (LC‑MS/MS)
If you require a customized PFAS compliance determination report for a specific product (e.g., PTFE catheter, implant, IVD consumable, PCTFE packaging), or a template letter to respond to customer or customs inquiries, please contact the CIRS Regulatory Compliance Service Team. At CIRS Testing, we help you navigate complex regulatory landscapes and ensure your products are safe and reliable. For any assistance or questions, feel free to reach out to us at test@cirs-group.com.